Fortune December 14, 2022
Bob Kocher and Bryan Roberts

Welcome back to predictions season. We are pleased to share what we see in our still murky, and materially more dinged-up, crystal ball for 2023. But first, let’s look back and see how we did with our 2022 predictions.

In 2022, we scored 7 out of 10, approaching our previous high-water mark of 8 out of 10 in 2021. We also want to note that one of our evergreen predictions–namely, nothing would happen on drug prices–was an epic fail after the passage of the Inflation Reduction Act.

Additionally, we did not predict that we would all wake up to 1970s-style inflation and a Fed hiking cycle. This caused a sudden end to…well, just about everything: growth financings,...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Digital Health, Govt Agencies, Insurance, Investments, Medicare Advantage, Mergers & Acquisitions / JV, Patient / Consumer, Payer, Provider, Technology, Telehealth, Trends
Inside A ComForCare Franchise’s Play To Blend Home Care, Senior Living
OpenAI’s $40 Billion And Circle IPO: AI And Blockchain’s Revolution
Debunked Episode 14: Is This a Good Time for a Digital Health IPO?
Q&A: Researcher discusses agentic AI, expected to be the next trend in digital medicine
4 Notable Health Tech Funding Announcements in March

Share This Article